Orli Even-Or
Director of R&D Coltac Therapeutics
Dr. Orli Even-Or is the Director of R&D at Coltac Therapeutics, where she leads strategy and development of molecular glues for targeted protein degradation. With over a decade of experience in biotech, she has driven programs from discovery through IND-enabling studies, managed global collaborations, and built high-performing teams.
Seminars
Thursday 29th January 2026
Advancing Molecular Glue Discovery through a Positive-Signal Bacterial Screening Platform
11:30 am
- Combining in-silico with the power of our bacteria-based, synthetic positive selection screening system for new molecular glues
- Program insights covering oncology and non-oncology programs, with focus on ligase diversity, target specificity, and optimization process
- Future directions that include expanding beyond degraders to explore non-degraders and PPI modulators, supporting both scientific advancement and company growth strategy
